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According to the SEGH report, the
task force's proposed formula allows for
future adjustment and is also flexible
enough to be used internationally, though
environmental standards for lead vary from
country to country. "Still," said Davies,
"our result is a starting point, not an end
point. We need to test these guidelines in
real-world situations. New information
will change some of the current concepts.
That's the way it should be."
To MTBE or Not to MTBE
Current efforts to protect people from the
dangers of carbon monoxide may be doing
more harm than good. In response to find-
ings that levels of carbon monoxide were
unusually high throughout U.S. cities, the
EPA mandated in 1992 that every state add
the oxygenates ethanol and methyl tertiary
butyl ether (MTBE) to gasoline to reduce
carbon monoxide emissions in problem
areas. The additives are used during the
winter months, when carbon monoxide
emissions are highest.
A year after the onset ofthe oxygenated
fuels program, the results in some states
haven't been what the EPA expected. North
Carolina is one state where the program has
not significantly reduced carbon monoxide
emissions.
In addition, studies have shown that
MTBE may be a carcinogen. The toxicity of
MTBE has become a major concern
because inhalation exposure to the com-
pound is widespread. There is also potential
for contamination of drinking water from
gasoline spills and leakage from under-
ground storage tanks.
Two studies have found that MTBE
causes tumors in mice and rats. An inhala-
tion study, conducted by H.D. Burleigh-
Flayer and colleagues at the Bushy Run
Research Center, Union Carbide Chemicals
and Plastics Company, Inc.,
in 1992 exposed groups of
50 CD-1 male and female
mice to MTBE at concen-
trations of 400, 3,000, and
8,000 parts per million
(ppm) for 6 hours a day, 5
days a week, for 18 months.
The MTBE caused an
increase of liver tumors at
the highest dose. There was
a statistically significant
increase in adenomas in
female mice, and a statisti-
cally significant increase in
carcinomas in male mice.
However, the study had to
be terminated early (at 18
months rather than 24
months as planned) due to
high-dose toxic effects.
Therefore, whether MTBE would have
affected mice in the lower-dose groups ifthe
study had continued is not known.
In an inhalation study conducted by
J.S. Chun and co-workers, also of Bushy
Run, in 1992, groups of50 F344 rats were
exposed to MTBE at the same concentra-
tions as in previous study. The low-dose
group was exposed for 24 months, the mid-
dose group for 97 weeks, and the high-dose
group for only 82 weeks, due to toxicity
leading to early mortality. In mid- and
high-dose groups ofmale rats, a statistically
significant increase in interstitial cell testicu-
lar tumors occurred that was clearly dose
related. The number of tumors in control
groups were high, but an increased number
of tumors in the treated groups was appar-
ent. Male rats in mid- and high-dose groups
also developed significant increases in kid-
ney tumors.
Preliminary results from an ongoing
study being conducted by Cesare Maltoni
and colleagues at the Collegium Ramazzini
in Italy also contribute to the weight of
information on the toxicity ofMTBE. This
study subjected Sprague Dawley rats to
MTBE by olive oil gavage for the lifetime of
the rats. Increases in several types oftumors
occurred at 250 milograms per kilogram
(mg/kg) and 1000 mg/kg MTBE, including
malignant sarcomas, testicular Leydig cell
tumors, hemolymphoreticular tumors, and
combined lymphomas and leukemias. Not
all dose groups have been reported.
Although these results are preliminary, they
are notable because tumors are being seen at
much lower concentrations of MTBE than
in the other two studies.
The EPA conducted a risk assessment
study last year using the results of the
Burleigh-Flayer and Chun studies, and tenta-
tively determined that there was no risk to
humans. The EPA conduded that there was
not enough evidence to assess the risk of
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Adding to the problem? New information fuels the debate over oxygenated gasoline.
MTBE because there are no pertinent
human data and stated that the controversy
around the animal studies warranted further
evaluation. The EPA cited "major uncertain-
ties" in the database ofthe rodent research,
pertaining to high-dose toxicity, possible
species specificity, and high spontaneous
background tumor incidence.
The EPA did consider Maltoni's results,
but decided theywere too preliminary at the
time to affect the risk assessment. No final
classification of MTBE was made. MTBE
was assigned a tentative "C" dassification, a
possible human carcinogen, based on limited
evidence.
Although Maltoni's results have yet to
be released, the existing evidence that
MTBE may be a human carcinogen has
led North Carolina officials to question its
use. A report on the public health impact
of the oxygenated fuels program was writ-
ten by the Environmental Epidemiology
Section ofthe North Carolina Department
of Environment, Health and Natural
Resources. The authors of the report con-
cluded that "the oxygenated fuels program
utilizing MTBE does not provide any pub-
lic health benefit in North Carolina at this
time and may indeed be posing an
increased health risk to the public."
The scientific advisory board to the
DEHNR in the Division ofEnvironmental
Management recentlyevaluated the evidence.
The scientific advisory board conducted its
own risk assessment and concluded that,
according to the National Toxicology
Program dassification ofcarcinogenic activi-
ty, there is "someevidence" forcarcinogenici-
ty of MTBE. The board added that if the
details ofthe Maltoni study are released and
reviewed and the preliminary results are con-
firmed, the data may support "dear evidence
ofcarcinogenicity."
The board also took into account that
there are other carcinogens already in gaso-
line, such as benzene (adass "A," or
known carcinogen). An argument
in favor of MTBE use is that it
reduces the amount of benzene in
gasoline. However, as the board
acknowledged, MTBE could act
synergistically with benzene, pro-
ducing adverse health effects.
Because there is no evidence on the
interactions between benzene and
MTBE, the board could not deter-
mine whether the addition of
MTBE alters the chemical compo-
sition of gasoline for the better or
worse.
The board concluded that the
state should consider requesting
that the EPA remove MTBE from
gasoline because ofthe uncertainties
surroundingit.
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